Catálogo de publicaciones - libros

Many new functional imaging techniques, with their strengths, weaknesses and costs, are expected to reach the clinic for early assessment of tumour response to new drugs in development. These allow an evaluation of the efficacy of innovative treatments in oncology, such as the anti-angiogenic and anti-vascular treatments that are in full expansion and are aimed at the destruction of tumour vascularisation.

In ultrasonography, the combination of perfusion software and contrast agents gives rise to a functional imaging method. The access to raw data and the development of software using the tracking of lesions permits a more precise and objective quantification of treatment efficiency to be performed.

Overall, it can be experienced that the public discussion on retailer-supplier collaboration in product development and launch is in an infancy stage. Yet, within the companies of retailers and suppliers major work is under way. Retailers are building up customer intelligence, strategic category management and capabilities to quickly turn product opportunities into profits. Suppliers are getting prepared to integrate information they get from retailers into their product creation processes, and are adjusting product, production and logistics design to deliver to retailer requests. So, it is probably not a speculation to say that one of the next fields for major improvement in the consumer goods industry is the redesign of the industry’s product development and launch processes.

In this article, we have briefly presented a general model for the Out-Of-Shelf, examined the results of the European Out-Of-shelf Index, which addresses only fast-moving items, and briefly presented our method of work for the development of a new algorithm that could capture more OOS cases. Yet, the development of precise association rules is a matter of investigation. The dynamically changing environment and the existence of divergent cases regarding the Out-Of-shelf problem do not permit the development of one solution that fits all cases. Thus, an OOS algorithm requires careful analysis of the problem, which could be served by the incorporation of several variables.

The previous discussion assumes that all the technical barriers regarding the application of RFID have been overcome, and that RF-tags have been introduced on all or a big proportion of consumer goods. However, this assumption is still far from reality, as technical barriers have not been totally overcome yet, especially when considering large-scale implementations, and standards are still evolving to support the wide adoption of RFID technology across the industry.

While research is progressing fast on the standards and technology front, there is an ever increasing concern about consumer privacy relating to the use of RF-tags on consumer goods, which has recently led companies like Benetton and Wal-Mart to temporarily shirk RFID-at-consumer-level pilots (McGinity, 2004). Analysts predict that while four or five years will pass before consumers are directly affected by RFID, privacy will be a major problem, if it isn’t addressed up-front. These concerns, in combination with the lower costs associated with introducing RF-tags on product cases and pallets instead of consumer units, currently lead the industry to implementing warehouse applications in the first round. Eventually, privacy concerns will be overcome, as has happened during the initial introduction of barcode technology several decades ago, allowing companies to adopt advanced RFID applications and smarter collaboration practices. This perspective opens up many new directions for research and development in this area, relating both to technology and the many different business aspects associated with it. The work presented in this paper is a first attempt towards this direction.

Many new functional imaging techniques, with their strengths, weaknesses and costs, are expected to reach the clinic for early assessment of tumour response to new drugs in development. These allow an evaluation of the efficacy of innovative treatments in oncology, such as the anti-angiogenic and anti-vascular treatments that are in full expansion and are aimed at the destruction of tumour vascularisation.

In ultrasonography, the combination of perfusion software and contrast agents gives rise to a functional imaging method. The access to raw data and the development of software using the tracking of lesions permits a more precise and objective quantification of treatment efficiency to be performed.

The previous discussion assumes that all the technical barriers regarding the application of RFID have been overcome, and that RF-tags have been introduced on all or a big proportion of consumer goods. However, this assumption is still far from reality, as technical barriers have not been totally overcome yet, especially when considering large-scale implementations, and standards are still evolving to support the wide adoption of RFID technology across the industry.

While research is progressing fast on the standards and technology front, there is an ever increasing concern about consumer privacy relating to the use of RF-tags on consumer goods, which has recently led companies like Benetton and Wal-Mart to temporarily shirk RFID-at-consumer-level pilots (McGinity, 2004). Analysts predict that while four or five years will pass before consumers are directly affected by RFID, privacy will be a major problem, if it isn’t addressed up-front. These concerns, in combination with the lower costs associated with introducing RF-tags on product cases and pallets instead of consumer units, currently lead the industry to implementing warehouse applications in the first round. Eventually, privacy concerns will be overcome, as has happened during the initial introduction of barcode technology several decades ago, allowing companies to adopt advanced RFID applications and smarter collaboration practices. This perspective opens up many new directions for research and development in this area, relating both to technology and the many different business aspects associated with it. The work presented in this paper is a first attempt towards this direction.

Overall, it can be experienced that the public discussion on retailer-supplier collaboration in product development and launch is in an infancy stage. Yet, within the companies of retailers and suppliers major work is under way. Retailers are building up customer intelligence, strategic category management and capabilities to quickly turn product opportunities into profits. Suppliers are getting prepared to integrate information they get from retailers into their product creation processes, and are adjusting product, production and logistics design to deliver to retailer requests. So, it is probably not a speculation to say that one of the next fields for major improvement in the consumer goods industry is the redesign of the industry’s product development and launch processes.

In this article, we have briefly presented a general model for the Out-Of-Shelf, examined the results of the European Out-Of-shelf Index, which addresses only fast-moving items, and briefly presented our method of work for the development of a new algorithm that could capture more OOS cases. Yet, the development of precise association rules is a matter of investigation. The dynamically changing environment and the existence of divergent cases regarding the Out-Of-shelf problem do not permit the development of one solution that fits all cases. Thus, an OOS algorithm requires careful analysis of the problem, which could be served by the incorporation of several variables.

Overall, it can be experienced that the public discussion on retailer-supplier collaboration in product development and launch is in an infancy stage. Yet, within the companies of retailers and suppliers major work is under way. Retailers are building up customer intelligence, strategic category management and capabilities to quickly turn product opportunities into profits. Suppliers are getting prepared to integrate information they get from retailers into their product creation processes, and are adjusting product, production and logistics design to deliver to retailer requests. So, it is probably not a speculation to say that one of the next fields for major improvement in the consumer goods industry is the redesign of the industry’s product development and launch processes.

Many new functional imaging techniques, with their strengths, weaknesses and costs, are expected to reach the clinic for early assessment of tumour response to new drugs in development. These allow an evaluation of the efficacy of innovative treatments in oncology, such as the anti-angiogenic and anti-vascular treatments that are in full expansion and are aimed at the destruction of tumour vascularisation.

In ultrasonography, the combination of perfusion software and contrast agents gives rise to a functional imaging method. The access to raw data and the development of software using the tracking of lesions permits a more precise and objective quantification of treatment efficiency to be performed.